Gniot M - Search Results

1

Prognostic Impact of Copy Number Alterations' Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy.

Libura M, Karabin K, Tyrna P, Czyż A, Makuch-Łasica H, Jaźwiec B, Paluszewska M, Piątkowska-Jakubas B, Zawada M, Gniot M, Trubicka J, Szymańska M, Borg K, Więsik M, Czekalska S, Florek I, Król M, Paszkowska-Kowalewska M, Gil L, Kapelko-Słowik K, Patkowska E, Tomaszewska A, Mądry K, Machowicz R, Czerw T, Piekarska A, Dutka M, Kopińska A, Helbig G, Gromek T, Lewandowski K, Zacharczuk M, Pastwińska A, Wróbel T, Haus O, Basak G, Hołowiecki J, Juszczyński P, Lech-Marańda E, Giebel S, Jędrzejczak WW. Libura M, et al. Among authors: gniot m. Cancers (Basel). 2023 Nov 15;15(22):5431. doi: 10.3390/cancers15225431. Cancers (Basel). 2023. PMID: 38001691 Free PMC article.

2

Dasatinib treatment can overcome imatinib and nilotinib resistance in CML patient carrying F359I mutation of BCR-ABL oncogene.

Barańska M, Lewandowski K, Gniot M, Iwoła M, Lewandowska M, Komarnicki M. Barańska M, et al. Among authors: gniot m. J Appl Genet. 2008;49(2):201-3. doi: 10.1007/BF03195613. J Appl Genet. 2008. PMID: 18436994

3

[Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net].

Sacha T, Zawada M, Czekalska S, Florek I, Mueller M, Gniot M, Jaźwiec B, Kyrcz-Krzemień S, Leszczyńska A, Lewandowski K, Matiakowska K, Solarska I, Stokłosa T, Skotnicki AB. Sacha T, et al. Among authors: gniot m. Przegl Lek. 2010;67(7):454-9. Przegl Lek. 2010. PMID: 21387754 Polish.

4

Bortezomib has little ex vivo activity in chronic myeloid leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia.

Styczyński J, Gil L, Czyżewski K, Kołodziej B, Kuryło-Rafińska B, Lewandowski K, Gniot M, Lewandowska M, Komarnicki M, Wysocki M. Styczyński J, et al. Among authors: gniot m. Contemp Oncol (Pozn). 2012;16(3):210-4. doi: 10.5114/wo.2012.29286. Epub 2012 Jul 6. Contemp Oncol (Pozn). 2012. PMID: 23788881 Free PMC article.

5

Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation.

Kaźmierczak M, Luczak M, Lewandowski K, Handschuh L, Czyż A, Jarmuż M, Gniot M, Michalak M, Figlerowicz M, Komarnicki M. Kaźmierczak M, et al. Among authors: gniot m. Med Oncol. 2013 Dec;30(4):725. doi: 10.1007/s12032-013-0725-2. Epub 2013 Oct 2. Med Oncol. 2013. PMID: 24085543 Free PMC article.

6

K356dup--an in-frame insertion in the BCR-ABL gene in an imatinib-resistant chronic myeloid leukemia.

Gniot M, Wasilewska EM, Lewandowski K. Gniot M, et al. Int J Lab Hematol. 2012 Dec;34(6):e3-6. doi: 10.1111/j.1751-553x.2012.01443.x. Int J Lab Hematol. 2012. PMID: 25998099 No abstract available.

7

Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome.

Piekarska A, Gil L, Prejzner W, Wiśniewski P, Leszczyńska A, Gniot M, Komarnicki M, Hellmann A. Piekarska A, et al. Among authors: gniot m. Ann Hematol. 2015 Nov;94(11):1891-7. doi: 10.1007/s00277-015-2457-1. Epub 2015 Jul 29. Ann Hematol. 2015. PMID: 26220759 Free PMC article.

8

B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib.

Lewandowski K, Gniot M, Lewandowska M, Wache A, Ratajczak B, Czyż A, Jarmuż-Szymczak M, Komarnicki M. Lewandowski K, et al. Among authors: gniot m. Case Rep Med. 2016;2016:9806515. doi: 10.1155/2016/9806515. Epub 2016 Mar 3. Case Rep Med. 2016. PMID: 27034682 Free PMC article.

9

Clonal chromosomal aberrations in Philadelphia negative cells such as monosomy 7 and trisomy 8 may persist for years with no impact on the long term outcome in patients with chronic myeloid leukemia.

Wasilewska EM, Panasiuk B, Gniot M, Sawicka A, Kozłowska K, Lewandowski K, Kłoczko J, Midro AT. Wasilewska EM, et al. Among authors: gniot m. Cancer Genet. 2017 Oct;216-217:1-9. doi: 10.1016/j.cancergen.2017.04.066. Epub 2017 Apr 28. Cancer Genet. 2017. PMID: 29025581

10

Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.

Lewandowski K, Gniot M, Wojtaszewska M, Kanduła Z, Becht R, Paczkowska E, Mędraś E, Wasilewska E, Iwoła M. Lewandowski K, et al. Among authors: gniot m. Int J Lab Hematol. 2018 Jun;40(3):366-371. doi: 10.1111/ijlh.12798. Epub 2018 Mar 6. Int J Lab Hematol. 2018. PMID: 29508552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters